Responses to ALK Inhibitor Treatments in a Patient with Non-Small Cell Lung Cancer Harboring a Novel HPCAL1-ALK Fusion Variant: A Case Report

Overview of attention for article published in OncoTargets and therapy, May 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (72nd percentile)

Mentioned by

twitter: 3 X users

Readers on

mendeley: 11 Mendeley

Summary X

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 2,626 followers.

PubMed_ Responses to ALK Inhibitor Treatments in a Patient with Non-Small Cell Lung Cancer Harboring a Novel HPCAL1-ALK Fusion Variant: A Case Report. https://t.co/whJfJvkg2S

12 Jun 2020

Reply Repost Favourite

Responses to ALK Inhibitor Treatments in a Patient with Non-Small Cell Lung Cancer Harboring a Novel HPCAL1-ALK Fusion Variant: A Case Report. https://t.co/p9lqtBdvPf https://t.co/DvxiLftjgX

12 Jun 2020

Reply Repost Favourite

Responses to ALK Inhibitor Treatments in a Patient with Non-Small Cell Lung Cancer Harboring a Novel HPCAL1-ALK Fusion Variant: A Case Report. #lymphoma #lymsm https://t.co/AQWq5JwWng

12 Jun 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Responses to ALK Inhibitor Treatments in a Patient with Non-Small Cell Lung Cancer Harboring a Novel HPCAL1-ALK Fusion Variant: A Case Report

About this Attention Score

Mentioned by

Readers on